Articles from BIOTECH Patent News (September 1, 2007)

1-29 out of 29 article(s)

Title	Type	Words
Aida granted additional anti-cancer patent.		374
Ajinomoto obtains United States patent.		102
Arius announces new findings in Trop-2 and CD59 CANCER antibody programs - CD59 antibody uses novel approach to "de-cloak" cancers -.		362
BASF obtains United States patent.		134
Bovaird & Co. obtains United States patent.	Brief article	128
Canadian Forest Service obtains United States patent.	Brief article	195
Celtrix obtains United States patent.		40
Degussa obtains United States patent.		71
Euroscreen obtains United States patent.	Brief article	67
Human Pheromone files patent application for wellness compound.	Brief article	312
MacroChem acquires rights to pexiganan for treatment of diabetic foot infections.		1268
Martek wins German patent infringement actions against Lonza.		374
Michigan Technological University obtains United States patent.		64
Monsanto obtains United States patent.		105
Monsanto obtains United States patent.		52
National Stem in final stage negotiations for exclusive licensing of its recently discovered biomaterial for anti-aging applications.		333
New United States patent granted for Nventa's Coval HPV fusions to treat patients with HPV-related diseases.		204
Orchid Cellmark to purchase ReliaGene.		395
Organizations from all 50 states speak out against proposed patent reform act.		675
Pharmacopeia acquires selective androgen receptor modulator program from Bristol-Myers.		380
ProChon obtains United States patent.		74
Quest Diagnostics licenses technology underlying SensiTrop HIV co-receptor tropism test from pathway diagnostics -First national diagnostic testing company to license proprietary technology-.		773
Salugen announces partnership with DNA Dimensions.		467
Sigma-Aldrich and Oxford BioMedica win key ruling in open biosystems patent Infringement dispute.		705
University of Maryland obtains United States patent.		88
University of Southern California obtains United States patent.		96
University of Wyoming obtains United States patent.		29
WellGen proceeds to build pipeline of patented nutraceuticals and advance product development programs.		451
Xenomics announces license with Asuragen for NPM1 leukemia diagnostics.		600